Elixinol Wellness Annual Report 2021

Consolidated Statement of Changes in Equity for the year ended 31 December 2021 Group Issued capital $’000 Foreign currency translation reserve $’000 Share-based payments reserve $’000 Accumulated losses $’000 Non- controlling interest $’000 Total equity $’000 Balance at ¡ January §¢§¢ ¡¥¥,¤¤¡ ¥,§©¡ ¨«« (¥ª,«££) (©¡) ¡¡¡,©¥§ (Loss)/profit after income tax expense for the year – – – (¡¢£,«¢ª) §¥ (¡¢£,£¤¥) Other comprehensive income for the year, net of tax – ¤¤ – – © ¥¢ Total comprehensive (loss)/ income for the year – ¤¤ – (¡¢£,«¢ª) ©¡ (¡¢£,©¨¥) Share-based payments (Note ©ª) – – (§¨§) – – (§¨§) Transactions with owners in their capacity as owners: Contributions of equity, net of transaction costs (Note §¡) §¥,¨«¨ – – – – §¥,¨«¨ Balance at ©¡ December §¢§¢ §¡¤,¤©¢ ¥,©¢¥ ªª© (¡¨¡,¢«¢) – ©«,ª«¡ Group Issued capital $’000 Foreign currency translation reserve $’000 Share-based payments reserve $’000 Accumulated losses $’000 Non- controlling interest $’000 Total equity $’000 Balance at ¡ January §¢§¡ , , ( , ) – , Loss after income tax benefit for the year – – – ( , ) – ( , ) Other comprehensive income for the year, net of tax – – – – Total comprehensive (loss)/ income for the year – – ( , ) – ( , ) Transactions with owners in their capacity as owners: Share-based payments (Note ©ª) – ( ) – – Share issue transaction costs (Note §¡) ( ) – – – – ( ) Balance at ©¡ December §¢§¡ , , ( , ) – , The above consolidated statement of changes in equity should be read in conjunction with the accompanying notes F INANCI AL REPORT 35 Company Overview Financial Report Shareholder Information Key Achievements and Milestones FY2021 Highlights